NYMOX PHARMACEUTICAL CORPORATION and _______________________________, as Trustee INDENTURE Dated as of ___________, 20__ Providing for the Issuance of Debt Securities CROSS-REFERENCE TABLE*Nymox Pharmaceutical Corp • December 9th, 2021 • In vitro & in vivo diagnostic substances • New York
THIS INDENTURE, between Nymox Pharmaceutical Corporation, a Bahamian corporation (hereinafter called the “Company”) having its principal office at Bay & Deveaux Streets, Nassau, The Bahamas, and, [ ], a [ ] as trustee (hereinafter called the “Trustee”), is made and entered into as of this [ ] day of [ ], 20[ ].
Nymox Pharmaceutical Corporation Bay & Deveaux Streets Nassau, The BahamasNymox Pharmaceutical Corp • December 9th, 2021 • In vitro & in vivo diagnostic substances
Reference is hereby made to that certain sales agreement (the “Agreement”), dated as of July 17, 2020, by and between Nymox Pharmaceutical Corporation (the “Company”) and A.G.P./Alliance Global Partners (“A.G.P.”).
